Acta Haematologica Oncologica Turcica is the official scientific publication of the Ankara Hematology Oncology Association. The journal is published every four months and features original research articles, case reports, and invited review articles in the fields of oncology, hematological malignancies, and transplantation. All manuscripts must be submitted in English.
Publication Principles
Manuscripts that have not been published elsewhere and that are not under review in another journal are accepted to the journal.
The scientific and legal responsibility of the articles belongs to the authors.
Authors must fully comply with research and publication ethics. Ethics committee approval (location information of the Ethics Committee, date and the number of the approval should be provided at the Material and Methods section of the main text).
The editorial and publication process of Acta Haematologica Oncologica Turcica are shaped in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics (COPE), European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal is in conformity with the Principles of Transparency and Best Practice in Scholarly Publishing.
Free-of-Charge Publication
No fee is charged from the authors during the submission, evaluation and publication process. Journal practices, ethical rules, technical information and necessary forms are specified on the journal's web page.
The manuscripts must be submitted via the Manuscript Manager online article system, represented on the journal website.
Copyright & Open Access Policy
Acta Haematologica Oncologica Turcica is an open access publication. Acta Haematologica Oncologica Turcica’s Open Access Policy is based on the rules of Budapest Open Access Initiative (BOAI). By “open access” to [peer-reviewed research literature], we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited.
All published content is available online, free of charge at actaoncologicaturcica.com.
Acta Haematologica Oncologica Turcica is protected by copyright laws. The journal is licensed under a Creative Commons AttributionNonCommercial 4.0 International (CC BY-NC-ND 4.0). The Copyright Agreement Form should be signed and attached to the submissions. By signing this form authors agree that the article, if accepted for publication Acta Haematologica Oncologica Turcica, will be licensed under a Creative Commons AttributionNonCommercial 4.0 International (CC BY-NC-ND 4.0) which permits third parties to copy and distribute the material in any medium or format in unadapted form only, for non-commercial purposes only, and only so long as attribution is given to the creator.
The copyright of the published article belongs to its author under CC BY-NC-ND 4.0 license.
The authors agree to transfer the commercial rights to Ankara Hematology Oncology Association if the article is accepted for publication.
CC BY-NC-ND license includes the following elements:
BY – Credit must be given to the creator
NC – Only noncommercial uses of the work are permitted
ND – No derivatives or adaptations of the work are permitted
Advertising Policy
This journal's advertising sales and editorial processes are separated to ensure editorial independence and reduce the effects of financial interests.
Advertisers are responsible for ensuring that their advertisements comply with applicable laws regarding deceptive and/or offensive content and ethical issues.
Material Disclaimer
Scientific and legal responsibilities pertaining to the papers belong to the authors. Contents of the manuscripts and accuracy of references are also the author’s responsibility. Ankara Hematology Oncology Association, the Editor, the Editorial Board or the publisher do not accept any responsibility for opinions expressed in articles.
Financial expenses of the journal are covered by Ankara Hematology Oncology Association.
Permission Requests
Permission required for use any published under CC BY-NC-ND license with commercial purposes (selling, etc.) to protect copyright owner and author rights). Republication and reproduction of images or tables in any published material should be done with proper citation of source providing author(s) name; article title; journal title; year (volume) and page of publication; copyright year of the article.
Digital Archiving and Preservation Policy
Digital preservation is a set of processes and activities that ensure the retrieval and distribution of information now available in digital formats to guarantee long-term, perpetual access. The preservation policy includes the following measures:
Website Archiving
All of the electronic content (website, manuscript, etc.) is stored in three different sources. Content on a server is online and accessible to readers. A copy of the same content is preserved as a backup on other servers. Should a server fail, other resources can be brought online, and the website is expected to be available in 24-36 hours.
Abstracting/Indexing Services
Our journal's Abstracting/Indexing services store essential information about articles. In addition, some of our journal’s Abstracting/Indexing services archive metadata about the article and electronic versions of the articles. In this way, copies of articles are presented to the scientific community through these systems as an alternative to journals.
Author Self-Archiving Policy
Authors are permitted and encouraged to post their articles on personal and institutional websites after publication (while providing full bibliographic details and a link to the original publication).
